63. NIH, ”Statistical Analysis Methods for Validating Risk Prediction Models”. From 14 to present.
AS CONSULTANT or MENTOR:
64. NCI, ”An Open-Source Algorithm Isolating Signatures in Microarray Data” (PI: Michael Ochs).
From 08 to 10.
65. NIH, ”Integrative Oncogenomics of Multiple Myeloma - Core E”. (PI: Nikhil Munshi). From 11
to present.
66. NIH, ”SPORE in Multiple Myeloma”. (PI: Kenneth Anderson). From 13 to present.
67. NIH, ”Host-Tumor Cell Interaction in Myeloma Therapeutic Applications”. (PI: Kenneth Ander-
son). From 13 to present
68. Burroughs Welcome Fund, ”Development of a Biomarker Enriched Adaptive Trial for Patients with
Glioblastoma”, (PI: Brian Alexander). From 14 to present
30
LECTURES
Named Lectures
1. Harvard School of Public Health, Department of Biostatistics, Myrto Lefkopoulou Distinguished
Lecture, September 1999: Breast Cancer Genes: Modeling and Medical Care.
2. Dana–Farber Cancer Center, October 2002: Dana Farber / Frontiers of Science Annual Lecture.
Statistical challenges in expression–based molecular classification of cancer.
3. University of California at Irvine, February 2009: Distinguished Speaker, Genetic Epidemiology
Research Institute. Risk prediction in familial cancer syndromes.
4. MRC Biostatistics Unit, Cambridge UK, November 2013: Armitage Lectureship. Cross Study
Reproducibility of Prognostic Signatures From High Throughput Genomic Data.
5. Universita di Perugia, Italy, July 2015: ”Top Italian Scientist” Seminar.
Grand Rounds
6. M. D. Anderson Cancer Center, Institutional Grand Rounds, October 2002: Breast Cancer Genes:
Modeling and Medical Care.
7. Department of Pathology, Johns Hopkins University, Nov 2006: Familial Risk Prediction: Examples
from Colon, Pancreas and Breast Cancer.
8. Massachusetts General Hospital, Breast Program, Feb 2008: Risk assessment in familial breast
and ovarian cancer.
9. Welch Center, Johns Hopkins University, Apr 2007: Comparing and combining multiple microarray
datasets.
10. Medical Grand Rounds at Juravinski Cancer Centre, Ontario, Nov 2016: Assessing Risk in Families
with Cancer.
11. Brigham and Women’s Hospital Pathology Grand Rounds, Dec 2016: Precision Genetic Risk
Assessment in Cancer.
Invited Lectures at Conferences
12. 40-th Seminar on Bayesian Inference in Econometrics and Statistics, Washington, March 1990:
Inspecting For Failures While Learning About the Failure Rate.
13. International Research Conference in Reliability, Columbia, MS, June 1991: Optimal Scheduling
of Inspections with Applications in Reliability and Bayesian Design.
14. 10th National Symposium of Probability and Statistics (SINAPE), Rio de Janeiro, August 1992:
Statistical Issues in Screening for Chronic Disease.
15. Joint Statistical Meetings, Boston, August 1992: Optimal Screening Ages.
16. 45-th Seminar on Bayesian Inference in Econometrics and Statistics, Durham, November 1992:
Sequential Design via Curve-Fitting of Monte-Carlo Experiments.
17. Stroke PORT Annual Meeting, Durham, December 1992: Modeling and Estimation Strategies for
Transition Probabilities.
18. Biometric Society ENAR Spring Meeting, Philadelphia, April 1993: Bayesian Methods in the
Design of Biomedical Experiments.
19. International Society for Bayesian Analysis annual Meeting, San Francisco, August 1993: Intro-
ducing Bayesian Statistics to Undergraduates.
31
20. Southeastern Regional Conference of Statisticians in the Health Care Industry, RTP, March 1994:
Bayesian Variable Selection and Prediction via Mixtures.
21. Royal Statistical Society of Spain, Madrid, June 1994: Information and Model Criticism.
22. International Society for Bayesian Analysis annual Meeting, Alicante, June 1994: Information and
Model Criticism.
23. 26th Symposium on the interface: Computing Science and Statistics, RTP, June 1994. Stochastic
Optimization by Curve Fitting of Monte-Carlo Experiments.
24. IMS Workshop: Directions in Sequential Analysis, Chapel Hill, June 1994: Stochastic Optimization
by Curve Fitting of Monte-Carlo Experiments.
25. Joint Statistical Meetings, Toronto, August 1994: Screening: is it all in the Timing?
26. American Statistical Association, Winter Conference, Raleigh, January 1995: Pre-analysis of super-
large data set.
27. Fourth Conference on Model-oriented Data Analysis, Spetzes, June 1995: Design of repeated
medical exams.
28. III World Meeting of the International Society for Bayesian Analysis, Oaxaca, Mexico, September
1995. Prediction via Model Mixing.
29. Biometric Society ENAR Spring Meeting, Richmond, March 1996. ”New strategies for model
mixing in biostatistical analysis”
30. INFORMS meeting, Washington, May 1996. Prediction via Model Mixing.
31. Institute for Mathematics and its Applications, Summer Program, July 1997, Minneapolis, MN.
Timing Medical Examination via Intensity Functions.
32. Annual NIH SPORE Investigators Meeting, Rockville, MD, July 1997 Decision model for assessing
the benefits of axillary lymph node dissection (ALND) in patients with breast cancer.
33. Fourth Workshop on Bayesian Statistics in Science and Technology: Case Studies Carnegie Mellon
University, Pittsburgh, September 1997. Modeling Risk of Breast Cancer and Decisions about
Genetic Testing.
34. Doing and Understanding Meta-analysis. Rockville, MD, October 1997. Combining Incomplete
Information on Headache Treatments.
35. International Conference on Health Policy Research: Methodologic Issues in Health Services
and Outcomes Research, Washington, DC, December 1997.
Assessing Uncertainty in Cost-
Effectiveness Analyses: Application to a Complex Decision Model
36. Bayesian Statistics VI, Valencia, Spain, June 1998. Decision Models in Screening for breast cancer.
37. Carcinogenesis Modeling and Risk Assessment Conference, Park City UT, July 1998. ”Semipara-
metric Bayesian models in risk analysis”.
38. Joint Statistical Meetings, Dallas, August 1998: Toward a Comprehensive Model of Breast Cancer
Risk.
39. Joint Working Group on Methodological Issues in Clinical Trials in Radiological Screening and
Related Computer Modeling, Washington, DC, January 1999: Uncertainty in decision models of
screening illustrated with examples in breast cancer and stroke.
40. Joint Statistical Meetings, Baltimore, August 1999: Bayesian Approaches to Sample Size Deter-
mination: Concepts, Applications and Computing.
41. Gertrude M Cox Statistics Conference Research Triangle Institute, RTP NC, September 1999.
Bayesian decision models and the genetics of breast cancer
42. International Workshop on Foundational Issues and Statistical Practice, Bibbiena, Italy, October
1999. Comprehensive medical decision models: toward a new foundational paradigm?
32